Successful Elosulfase Alfa Desensitization Protocol in a Patient With Morquio A Syndrome.
Where this comes from
- Record sourced from PubMed, PMID 35059725.
- Also identified by DOI 10.1542/peds.2021-052648.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with lysosomal storage diseases may require modifications to standard drug desensitization protocols; personalized medicine as well as development of new treatment options are needed.
Medical subject headings
- Chondroitinsulfatases
- Mucopolysaccharidosis IV